Chemometec’s new growth engine could attract buyers
Chemometec is banking big on a new analysis device, scheduled for a broad launch during 2017. If the product lives up to the company’s own expectations, it could have wide-reaching consequences for the medtech company, one analyst believes.
BY ELIZABETH MØNSTED JOHANSEN
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.